Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients

Heather A. Brandling-Bennett, Seattle Children's Hospital, Seattle, Washington; Division of Dermatology, Department of Pediatrics, University of Washington, Seattle, Washington. Electronic address: heather.brandling-bennett@seattlechildrens.org.
Lisa M. Arkin, Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Yvonne E. Chiu, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Adelaide A. Hebert, Department of Dermatology, UTHealth McGovern Medical School at Houston, Houston, Texas.
Jeffrey P. Callen, Department of Dermatology, University of Louisville School of Medicine, Louisville, Kentucky.
Leslie Castelo-Soccio, Dermatology Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Dominic O. Co, Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Kelly M. Cordoro, Department of Dermatology, University of California, San Francisco, San Francisco, California.
Megan L. Curran, Division of Rheumatology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
Austin M. Dalrymple, Division of Rheumatology, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri; SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri.
Carsten Flohr, Department of Paediatric Dermatology, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Ken B. Gordon, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Diane Hanna, Modern Dermatology, Shawnee, Kansas.
Alan D. Irvine, Department of Paediatric Dermatology, Trinity College Dublin, Dublin, Ireland.
Susan Kim, Department of Dermatology, University of California, San Francisco, San Francisco, California.
A Yasmine Kirkorian, Department of Dermatology, George Washington University School of Medicine & Health Sciences, Washington, District of Columbia; Children's National Hospital, Washington, District of Columbia.
Irene Lara-Corrales, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Jill Lindstrom, Walter Reed National Military Medical Center, Bethesda, Maryland.
Amy S. Paller, Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Melissa Reyes, Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland.
Wendy Smith Begolka, National Eczema Association, Novato, California.
Wynnis L. Tom, Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Rady Children's Hospital-San Diego, San Diego, California.
Abby S. Van Voorhees, Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.
Ruth Ann Vleugels, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
Lara Wine Lee, Department of Dermatology, Medical University of South Carolina, Charleston, South Carolina.
Olivia Davies, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Elaine C. Siegfried, Division of Rheumatology, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri; SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri.

Document Type

Journal Article

Publication Date

2-9-2024

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2023.12.074

Keywords

adolescent; child; consensus; guidelines; methotrexate; pediatric

Department

Dermatology

Link to Full Text

Share

COinS